Treatment · June 22, 2026
FDA and EMA Accept Regeneron Drug for Rare Muscle Disease Review
Regeneron's drug application for cemdisiran is accepted for FDA and EMA review, advancing treatment options for patients....
Treatment · April 23, 2026
Regeneron Offers Free Hearing Loss Gene Therapy in Drug Pricing Deal
Regeneron commits to providing a new hearing-loss gene therapy at no cost to patients....